Table: Modalis Therapeutics - 9-MTH group results

Modalis Therapeutics

07/11/2022 06:00

Nov 7 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Dec 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            40 mln               1 mln                     
                                     (-99.7 pct)                  
  Operating       loss 1.44         loss 677 mln                  
  Recurring       loss 1.31         loss 661 mln                  
  Net             loss 1.31         loss 181 mln                  
  EPS          loss 45.04 yen       loss 6.32 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T